MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurose, H.
Right arrow Articles by Lefkowitz, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurose, H.
Right arrow Articles by Lefkowitz, R. J.

Characterization of alpha 2-adrenergic receptor subtype-specific antibodies

H Kurose, JL Arriza and RJ Lefkowitz

Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Subtypes of alpha 2-adrenergic receptors have been defined pharmacologically in a variety of mammalian tissues. The alpha 2A, alpha 2B, alpha 2C, and most recently alpha 2D subtypes have been characterized by their affinities for selective receptor antagonists and agonists. The genes that may encode the alpha 2A, alpha 2B, and alpha 2C subtypes have been identified in human and rat. In human these genes are termed alpha 2-C10, alpha 2-C2, and alpha 2-C4, respectively, based on their chromosomal localization, whereas three genes, designated RG20 alpha 2, RNG alpha 2, and RG10 alpha 2, are thought to be the corresponding rat homologues. These assignments were based on the pharmacology of the cloned receptor genes expressed in transfected cells and on the detection of homologous mRNAs by Northern blot analyses in cell lines or tissues with pharmacologically defined alpha 2-adrenergic receptors. However, the subtype assignment of cloned genes has not been fully resolved by these means. To help clarify the subtype assignment, we have raised antibodies against sequences from the divergent third intracellular loop of the human and rat alpha 2- adrenergic receptors. These antibodies were found to be subtype specific in immunoprecipitating either the cloned receptors expressed by DNA transfection or the pharmacologically defined receptors prepared from various tissues. Our immunological data corroborate the assignments of alpha 2-C2/RNG alpha 2 as encoding the alpha 2B subtype in NG108-15 cells and rat neonatal lung and of alpha 2-C4/RG10 alpha 2 as encoding the alpha 2C subtype in opossum kidney cells. Furthermore, antibodies against alpha 2-C10 and RG20 alpha 2 but not alpha 2-C2/RNG alpha 2 or alpha 2-C4/RG10 alpha 2 were both found to recognize alpha 2- adrenergic receptors expressed in rat submaxillary glands and in bovine pineal gland, two tissues with alpha 2D pharmacology. Because three genes were identified in the rat and human genome, these data suggest that the pharmacologically defined "alpha 2D receptor" is genetically of the alpha 2A subtype.

Volume 43, Issue 3, pp. 444-450, 03/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Nishida, S. Tanabe, Y. Maruyama, S. Mangmool, K. Urayama, Y. Nagamatsu, S. Takagahara, J. H. Turner, T. Kozasa, H. Kobayashi, et al.
G{alpha}12/13- and Reactive Oxygen Species-dependent Activation of c-Jun NH2-terminal Kinase and p38 Mitogen-activated Protein Kinase by Angiotensin Receptor Stimulation in Rat Neonatal Cardiomyocytes
J. Biol. Chem., May 6, 2005; 280(18): 18434 - 18441.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. J. CHEN, H. ZHU, and J. E. PILETZ
Intracellular Effect of Imidazoline Receptor on {alpha}2A-Noradrenergic Receptor
Ann. N.Y. Acad. Sci., December 1, 2003; 1009(1): 427 - 438.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Kintsurashvili, I. Gavras, C. Johns, and H. Gavras
Effects of Antisense Oligodeoxynucleotide Targeting of the {alpha}2B-Adrenergic Receptor Messenger RNA in the Central Nervous System
Hypertension, November 1, 2001; 38(5): 1075 - 1080.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Liang, M. G. Eason, E. A. Jewell-Motz, M. A. Williams, C. T. Theiss, G. W. Dorn II, and S. B. Liggett
Phosphorylation and Functional Desensitization of the alpha 2A-Adrenergic Receptor by Protein Kinase C
Mol. Pharmacol., July 1, 1998; 54(1): 44 - 49.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
A. Ulloa-Aguirre, D. Stanislaus, V. Arora, J. Vaananen, S. Brothers, J. A. Janovick, and P. M. Conn
The Third Intracellular Loop of the Rat Gonadotropin-Releasing Hormone Receptor Couples the Receptor to Gs- and Gq/11-Mediated Signal Transduction Pathways: Evidence from Loop Fragment Transfection in GGH3 Cells
Endocrinology, May 1, 1998; 139(5): 2472 - 2478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Jewell-Motz and S. B. Liggett
G Protein-coupled Receptor Kinase Specificity for Phosphorylation and Desensitization of alpha 2-Adrenergic Receptor Subtypes
J. Biol. Chem., July 26, 1996; 271(30): 18082 - 18087.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Shiina, A. Kawasaki, T. Nagao, and H. Kurose
Interaction with beta -Arrestin Determines the Difference in Internalization Behavior between beta 1- and beta 2-Adrenergic Receptors
J. Biol. Chem., September 8, 2000; 275(37): 29082 - 29090.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics